drugset / Trial / NCT06135259
Topical Erythropoietin Hydrogel in Management of Oral Lichen Planus
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to compare the clinical efficacy of erythropoietin gel containing a solution of 4000 units with triamcinolone acetonide 0.1% gel in the treatment of symptomatic oral lichen planus (OLP)
Timeline
- Start
- 2024-05-20
- Primary completion
- 2024-07-23
- Completion
- 2024-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Triamcinolone Acetonide | Other / unclassified | 0.1 mg | Topical |
| Comparator | Triamcinolone Acetonide | Other / unclassified | 0.1 % | Topical |
| Subject | epoetin alfa | Protein / enzyme biologic | 150 unknown | Topical |
| Subject | epoetin alfa | Protein / enzyme biologic | 300 unknown | Topical |
| Subject | epoetin alfa | Protein / enzyme biologic | 500 unknown | Topical |